StrepBStick One Step Test # R-6015
Group B streptococci are most notable for their role in causing neonatal sepsis and meningitis. Two forms of neonatal infection have been recognized on clinical and epidemiological grounds:
(a) Early onset disease, which usually occurs within the first 10 days after delivery.
(b) Late onset disease, which usually, though not always, occurs 10 days after birth. Late onset disease may be due to nosocomial acquisition of the organism and is rarely associated with material or obstetric complications. Early onset disease is thought to be due to acquisition, perhaps by aspiration, of the organism from the mother's genital tract at the time of delivery. The incidence of Group B Streptococci range from 1 to 5% of live births with mortality rates from 22 to 80%. In order to properly treat the disease using antibiotic therapy, it is important to use an accurate diagnostic method to identify the pathologic agent. Different methods are currently used for detection of Group B Streptococci including cellular culture, immunofluorescence, enzyme immunoassay, or latex agglutination.
The One Step Strep B Stick test (Cat. No. R-6015) is a rapid qualitative one step assay for the detection of Streptococcus Group B antigen from vagina swab specimens.
FOR FURTHER INFORMATION EMAIL US OR CALL: +972-2-6781861